↓ Skip to main content

Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3

Overview of attention for article published in BMC Cancer, January 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
32 Mendeley